Home › Burkitt Lymphoma › Minnesota › Minneapolis
Pag-aaral pangklinika para sa Burkitt Lymphoma sa Minneapolis, MN
9 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Minneapolis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 2
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Nagre-recruitPhase 3
- Abbott-Northwestern Hospital, Minneapolis
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Nagre-recruitPhase 2
- University of Minnesota/Masonic Cancer Center, Minneapolis
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 1
- University of Minnesota, Minneapolis
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 2
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Nagre-recruitPhase 3
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Nagre-recruitPhase 2
- Children's Hospitals and Clinics of Minnesota, Minneapolis
Allo HSCT Using RIC and PTCy for Hematological Diseases
Nagre-recruitPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Nagre-recruitPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod
- Houston, TX21 pag-aaral
- Philadelphia, PA16 pag-aaral
- Milwaukee, WI16 pag-aaral
- Chicago, IL15 pag-aaral
- Cincinnati, OH13 pag-aaral
- New York City, NY13 pag-aaral
- Atlanta, GA12 pag-aaral
- Aurora, CO11 pag-aaral
- Seattle, WA11 pag-aaral
- Durham, NC10 pag-aaral
- Boston, MA10 pag-aaral
- Kansas City, MO10 pag-aaral
Iba pang pag-aaral sa Minneapolis
- Non-Small Cell Lung Cancer27 pag-aaral
- Kanser sa Suso27 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Kanser sa Prostate23 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Pagkabigo ng Puso21 pag-aaral
- Acute Myeloid Leukemia20 pag-aaral
- Kanser sa Baga20 pag-aaral
- Colorectal Cancer19 pag-aaral
- Kanser ng Endometrium18 pag-aaral
- Sakit ni Parkinson17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.